- Home
- CNTX vs ALPS Comparison
CNTX vs ALPS Comparison
Compare CNTX & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.06
Company Overview
Basic Information| Metric | CNTX | ALPS |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.9M | 121.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTX | ALPS |
|---|---|---|
| Price | $1.06 | $1.25 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $5.40 | N/A |
| AVG Volume (30 Days) | 322.9K | ★ 1.0M |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.49 | $0.56 |
| 52 Week High | $1.65 | $15.00 |
Technical Indicators
Market Signals| Indicator | CNTX | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 43.17 | N/A |
| Support Level | $1.00 | N/A |
| Resistance Level | $1.18 | N/A |
| Average True Range (ATR) | 0.10 | 0.00 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 23.56 | 0.00 |
Price Performance
Historical Comparison CNTX
ALPS
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.